Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × Flow Cytometry × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Follicular 7 Lymphoma, B-Cell, Marginal Zone 7 Congenital Abnormalities 7 Multiple Myeloma 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, Mantle-Cell 6 Leukemia, Myeloid, Acute 6 Leukemia 6 Sezary Syndrome 5 Myelodysplastic Syndromes 5 Mycosis Fungoides 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma 5 Burkitt Lymphoma 5 Waldenstrom Macroglobulinemia 4 Myeloproliferative Disorders 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Extranodal NK-T-Cell 4 Lung Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Blast Crisis 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Leukemia, Myeloid, Chronic-Phase 3

Interventions

Paclitaxel 33 pembrolizumab 30 Carboplatin 28 Cyclophosphamide 18 Albumin-Bound Paclitaxel 18 Taxes 15 130-nm albumin-bound paclitaxel 15 Doxorubicin 14 atezolizumab 13 Capecitabine 13 Cisplatin 11 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 talazoparib 5 durvalumab 5 Everolimus 5 Biopsy 5 Bevacizumab 5 spartalizumab 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 sacituzumab govitecan 3 entinostat 3 bintrafusp alfa protein, human 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡